(Q35031722)

5 August 2017

1 reference

title

Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant? (English)

1 reference

5 August 2017

2

Henry Krum

1 reference

5 August 2017

1

Jennifer Martin

1 reference

5 August 2017

publication date

1 January 2003

1 reference

5 August 2017

1 reference

5 August 2017

volume

26

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

13-21

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

5 August 2017

cites work

1 reference

12 December 2020

Mechanistic studies on metabolic interactions between gemfibrozil and statins

1 reference

12 December 2020

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

12 December 2020

Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine

1 reference

12 December 2020

Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Inhibitory effects of verapamil and diltiazem on simvastatin metabolism in human liver microsomes

1 reference

12 December 2020

Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals

1 reference

12 December 2020

Lovastatin and rhabdomyolysis

1 reference

12 December 2020

Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin

1 reference

12 December 2020

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

1 reference

12 December 2020

Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.

1 reference

12 December 2020

Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin

1 reference

12 December 2020

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

12 December 2020

Withdrawal of cerivastatin from the world market

1 reference

12 December 2020

Effect of itraconazole on the pharmacokinetics of atorvastatin

1 reference

12 December 2020

Rhabdomyolysis due to interaction of simvastatin with mibefradil

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone

1 reference

12 December 2020

Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors

1 reference

12 December 2020

Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations

1 reference

12 December 2020

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin

1 reference

12 December 2020

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

12 December 2020

The potential for drug interactions with statin therapy in Ireland

1 reference

12 December 2020

Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients

1 reference

12 December 2020

Acute heart transplant rejection due to Saint John's wort

1 reference

12 December 2020

Pharmacological interactions of statins.

1 reference

12 December 2020

Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients

1 reference

12 December 2020

Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

1 reference

12 December 2020

HMG-CoA reductase inhibitors and myotoxicity

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

The interaction of diltiazem with lovastatin and pravastatin

1 reference

12 December 2020

Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions

1 reference

12 December 2020

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).

1 reference

12 December 2020

Rhabdomyolysis associated with lovastatin and erythromycin use.

1 reference

12 December 2020

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine

1 reference

12 December 2020

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

12 December 2020

HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin

1 reference

12 December 2020

Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians

1 reference

12 December 2020

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

1 reference

12 December 2020

10.2165/00002018-200326010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1040226764

0 references

1 reference